Bacteria defend against phages through type IV pilus glycosylation

Bacterial surface structures such as type IV pili are common receptors for phage. Strains of the opportunistic pathogen Pseudomonas aeruginosa express one of five different major type IV pilin alleles, two of which are glycosylated with either lipopolysaccharide O-antigen units or polymers of D-arabinofuranose. Here we show that both these post-translational modifications protect P. aeruginosa from a variety of pilus-specific phages. We identified a phage capable of infecting strains expressing both non-glycosylated and glycosylated pilins, and through construction of a chimeric phage, traced this ability to its unique tail proteins. Alteration of pilin sequence, or masking of binding sites by glycosylation, both block phage infection. The energy invested by prokaryotes in glycosylating thousands of pilin subunits is thus explained by the protection against phage predation provided by these common decorations. SIGNIFICANCE Post-translational modification of bacterial and archaeal surface structures such as pili and flagella is widespread, but the function of these decorations is not clear. We propose that predation by bacteriophages that use these structures as receptors selects for strains that mask potential phage binding sites using glycosylation. Phages are of significant interest as alternative treatments for antibiotic-resistant pathogens, but the ways in which phage interact with host receptors are not well understood. We show that specific phage tail proteins allow for infection of strains with glycosylated pili, providing a foundation for the creation of designer phages that can circumvent first-line bacterial defenses.

[1]  Y. Que,et al.  Synergistic Interaction Between Phage Therapy and Antibiotics Clears Pseudomonas Aeruginosa Infection in Endocarditis and Reduces Virulence , 2016, The Journal of infectious diseases.

[2]  E. Egelman,et al.  Structure of the Neisseria meningitidis Type IV pilus , 2016, Nature Communications.

[3]  Jason W. Labonte,et al.  Structural Diversity in the Type IV Pili of Multidrug-resistant Acinetobacter* , 2016, The Journal of Biological Chemistry.

[4]  A. Buckling,et al.  Prophages mediate defense against phage infection through diverse mechanisms , 2016, The ISME Journal.

[5]  L. Burrows,et al.  Structural and Functional Studies of the Pseudomonas aeruginosa Minor Pilin, PilE* , 2015, The Journal of Biological Chemistry.

[6]  M. Nilges,et al.  Neisseria meningitidis Type IV Pili Composed of Sequence Invariable Pilins Are Masked by Multisite Glycosylation , 2015, PLoS pathogens.

[7]  P. Castric,et al.  The group I pilin glycan affects type IVa pilus hydrophobicity and twitching motility in Pseudomonas aeruginosa 1244. , 2015, Microbiology.

[8]  Mike Boots,et al.  Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense , 2015, Current Biology.

[9]  A. Buckling,et al.  Experimental evolution and bacterial resistance: (co)evolutionary costs and trade-offs as opportunities in phage therapy research , 2015, Bacteriophage.

[10]  Y. Hao,et al.  Type IV Pilus Glycosylation Mediates Resistance of Pseudomonas aeruginosa to Opsonic Activities of the Pulmonary Surfactant Protein A , 2015, Infection and Immunity.

[11]  M. Brockhurst,et al.  Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections , 2014, The ISME Journal.

[12]  L. Burrows,et al.  Pseudomonas aeruginosa Minor Pilins Prime Type IVa Pilus Assembly and Promote Surface Display of the PilY1 Adhesin* , 2014, The Journal of Biological Chemistry.

[13]  T. Sampson,et al.  Alternative Roles for CRISPR/Cas Systems in Bacterial Pathogenesis , 2013, PLoS pathogens.

[14]  Shuai Le,et al.  Mapping the Tail Fiber as the Receptor Binding Protein Responsible for Differential Host Specificity of Pseudomonas aeruginosa Bacteriophages PaP1 and JG004 , 2013, PloS one.

[15]  Rotem Sorek,et al.  CRISPR-mediated adaptive immune systems in bacteria and archaea. , 2013, Annual review of biochemistry.

[16]  Alan R. Davidson,et al.  Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system , 2012, Nature.

[17]  M. Brockhurst,et al.  Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa , 2012, BMC Microbiology.

[18]  L. Burrows Pseudomonas aeruginosa twitching motility: type IV pili in action. , 2012, Annual review of microbiology.

[19]  J. Engel,et al.  Pseudomonas aeruginosa Pili and Flagella Mediate Distinct Binding and Signaling Events at the Apical and Basolateral Surface of Airway Epithelium , 2012, PLoS pathogens.

[20]  J. Kelly,et al.  Pseudomonas aeruginosa d-Arabinofuranose Biosynthetic Pathway and Its Role in Type IV Pilus Assembly* , 2011, The Journal of Biological Chemistry.

[21]  J. Lam,et al.  Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide , 2011, Front. Microbio..

[22]  M. Wolfgang,et al.  Infection of human mucosal tissue by Pseudomonas aeruginosa requires sequential and mutually dependent virulence factors and a novel pilus‐associated adhesin , 2010, Cellular microbiology.

[23]  L. Burrows,et al.  Pseudomonas aeruginosa minor pilins are incorporated into type IV pili. , 2010, Journal of molecular biology.

[24]  Sylvain Moineau,et al.  Bacteriophage resistance mechanisms , 2010, Nature Reviews Microbiology.

[25]  L. Burrows,et al.  Single-Residue Changes in the C-Terminal Disulfide-Bonded Loop of the Pseudomonas aeruginosa Type IV Pilin Influence Pilus Assembly and Twitching Motility , 2009, Journal of bacteriology.

[26]  G. O’Toole,et al.  Interaction between Bacteriophage DMS3 and Host CRISPR Region Inhibits Group Behaviors of Pseudomonas aeruginosa , 2008, Journal of bacteriology.

[27]  J. Kelly,et al.  Modification of Pseudomonas aeruginosa Pa5196 Type IV Pilins at Multiple Sites with d-Araf by a Novel GT-C Family Arabinosyltransferase, TfpW , 2008, Journal of bacteriology.

[28]  L. Burrows,et al.  Novel Proteins That Modulate Type IV Pilus Retraction Dynamics in Pseudomonas aeruginosa , 2008, Journal of bacteriology.

[29]  L. Craig,et al.  Type IV pili: paradoxes in form and function. , 2008, Current opinion in structural biology.

[30]  G. Lau,et al.  Genome sequence comparison and superinfection between two related Pseudomonas aeruginosa phages, D3112 and MP22. , 2007, Microbiology.

[31]  B. Maier,et al.  Pseudomonas aeruginosa Type IV Pilus Expression in Neisseria gonorrhoeae: Effects of Pilin Subunit Composition on Function and Organelle Dynamics , 2007, Journal of bacteriology.

[32]  J. Brisson,et al.  Glycosylation of Pseudomonas aeruginosa Strain Pa5196 Type IV Pilins with Mycobacterium-Like α-1,5-Linked d-Araf Oligosaccharides , 2006, Journal of bacteriology.

[33]  D. Stolz,et al.  Influence of Pilin Glycosylation on Pseudomonas aeruginosa 1244 Pilus Function , 2005, Infection and Immunity.

[34]  John A. Tainer,et al.  Type IV pilus structure and bacterial pathogenicity , 2004, Nature Reviews Microbiology.

[35]  M. Weinbauer Ecology of prokaryotic viruses. , 2004, FEMS microbiology reviews.

[36]  L. Burrows,et al.  Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. , 2004, Microbiology.

[37]  John A Tainer,et al.  Type IV pilin structure and assembly: X-ray and EM analyses of Vibrio cholerae toxin-coregulated pilus and Pseudomonas aeruginosa PAK pilin. , 2003, Molecular cell.

[38]  J. Lam,et al.  Glycosylation of Pseudomonas aeruginosa 1244 pilin: glycan substrate specificity , 2002, Molecular microbiology.

[39]  C. Deal,et al.  Identification of the Pseudomonas aeruginosa 1244 Pilin Glycosylation Site , 2002, Infection and Immunity.

[40]  R. Carlson,et al.  Structural Characterization of the Pseudomonas aeruginosa 1244 Pilin Glycan* , 2001, The Journal of Biological Chemistry.

[41]  H. Schweizer,et al.  A broad-host-range Flp-FRT recombination system for site-specific excision of chromosomally-located DNA sequences: application for isolation of unmarked Pseudomonas aeruginosa mutants. , 1998, Gene.

[42]  H. Hahn,et al.  The type-4 pilus is the major virulence-associated adhesin of Pseudomonas aeruginosa--a review. , 1997, Gene.

[43]  T. Pitt,et al.  Pilus-dependence of four Pseudomonas aeruginosa bacteriophages with non-contractile tails. , 1974, The Journal of general virology.

[44]  D. E. Bradley,et al.  The adsorption of Pseudomonas aeruginosa pilus-dependent bacteriophages to a host mutant with nonretractile pili. , 1974, Virology.

[45]  D. E. Bradley Basic Characterization of a Pseudomonas aeruginosa Pilus-Dependent Bacteriophage with a Long Noncontractile Tail , 1973, Journal of virology.

[46]  D. E. Bradley Stimulation of pilus formation in Pseudomonas aeruginosa by RNA bacteriophage adsorption. , 1972, Biochemical and biophysical research communications.

[47]  A. Davidson,et al.  Long noncontractile tail machines of bacteriophages. , 2012, Advances in experimental medicine and biology.

[48]  Rob Lavigne,et al.  Phage proteomics: applications of mass spectrometry. , 2009, Methods in molecular biology.

[49]  大濱 稔 Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice , 2006 .

[50]  J. Mattick Type IV pili and twitching motility. , 2002, Annual review of microbiology.